Nuvation Bio Inc. Shares Issued, Price Per Share
Nuvation Bio Inc. (NUVB) had Shares Issued, Price Per Share of $3.23 per share as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes
us-gaap:SharesIssuedPricePerShare · last filed 2025-03-06
- 2024-12-31: Shares Issued, Price Per Share $3.23.
- 2024-09-30: Shares Issued, Price Per Share $3.23.
- 2024-06-30: Shares Issued, Price Per Share $3.23.
- 2024-03-31: Shares Issued, Price Per Share $0.26.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2024-12-31 | $3.23 10-K · filed 2025-03-06 |
| 2024-09-30 | $3.23 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.23 10-Q · filed 2024-08-05 |
| 2024-03-31 | $0.26 8-K/A · filed 2024-06-20 |
| 2020-12-31 | $18.00 10-K/A · filed 2021-05-21 |
| 2020-09-30 | $18.00 10-Q · filed 2020-11-16 |
| 2020-06-30 | $18.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |